Loading...
Loading...
Below are the top 5 small-cap biotechnology stocks on the NASDAQ and the NYSE in terms of ROE.
Obagi Medical Products Inc
OMPI has a trailing-twelve-month ROE of 18.57%. OMPI’s quarterly earnings grew by 197.50% year-over-year.
Medicis Pharmaceutical Corp
MRX has a trailing-twelve-month ROE of 16.66%. MRX’s quarterly earnings growth stands at 10,651.10% year-over-year.
American Oriental Bioengineering Inc
AOB has a trailing-twelve-month ROE of 9.94%. AOB lost 38.90% during the past 52 weeks, while the S&P 500 rose 17.88% over the same period.
Emergent BioSolutions Inc
EBS has a trailing-twelve-month ROE of 9.82%. EBS has a 52 week trading range of $11.67-$19.95.
3SBio Inc
SSRX has a trailing-twelve-month ROE of 9.51%. SSRX has a quarterly earnings growth of 67.80% year-over-year.
Read more
from Benzinga's Company news.
Learn how to find the best
stocks to trade each day in our 70 page E-Book and 90 minute online video for free.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Posted In: EarningsLong IdeasNewsMarketsTrading IdeasBiotechnology Industryhighest return on equitysmall-cap stocks
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in